PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links


Article published in Urologia Polska 2000/53/3.

authors

Tomasz Demkow
Klinika Nowotworów Układu Moczowego Instytutu Onkologii w Warszawie
Kierownik Kliniki: dr med. T. Demkow

keywords

testis cancer chemotherapy fertility

references

  1. [1] Aass, N., Fossa, D. S., Theodorsen, L., Norman, N.: Prediction of long-term
  2. gonadal toxicity after standard treatment for testicular cancer. Eur. J. Cancer 1991,
  3. 27, 1087-1091.
  4. [2] Alvarez, R., Tusell, L., Genesca, A., Miro, R., Egozcue, J.: Absence of
  5. chromosomal instability in spermatozoa of men affected by testicular cancer. Hum.
  6. Reprod. 1991,14, 247-251.
  7. [3] Berthelsen, J. G.: Testicular cancer and fertility. Int. J. Androl. 1987,10, 371-
  8. 373.
  9. [4] Berthelsen, J. G., Skakkebaek, N. E.: Gonadal function in men with testis
  10. cancer. Ferii. Steril. 1983, 39, 68-75.
  11. [5] Boyer, M., Raghavan, D.: Toxicity of germ cell tumours. Semin. Oncol. 1992,
  12. 19, 128-142.
  13. [6] Brandiff, B. F., Meistrich, M. L.: Chromosomal damage in sperm of patients
  14. surviving Hodgkins disease following MOPP therapy with and without radiother-
  15. apy. Hum. Genet. 1994, 93, 295-299.
  16. [7] Brenneman, W., Stoffel-Wagner, B., Wischers, M: Pre-treatmentfolliculo-
  17. stimulating hormone: a prognostic serum marker of spermatogenesis status in pa-
  18. tients treated for germ cell cancer. J. Urol. 1998,159,1942-1946.
  19. [8] Byrne, J., Mulvihill, J. J.: Effects of treatment on fertility in long-term surui-
  20. vors of childhood or adolescent cancer. N. Eng. J. Med. 1987, 317,1315-1321.
  21. [9] Carlson, H. E.: Gynecomastia. N. Eng. J. Med. 1980,303, 795-799.
  22. [10] Carroll, P. R., Whitmore, W. F., Richardson, M.: Testicular failure in patients
  23. with extragonadal germ cell tumors. Cancer 1987, 60,108-113.
  24. [11] Carroll, P. R., Morse, M. J., Whitmore, W. F.: Fertility status of patients
  25. with clinical stage. I testis tumours on a surueillanceprotocol. J. Urol. 1987,138,70-
  26. 72.
  27. [12] Carter, M.: Fertility in the testicular cancer patients. World J. Urol. 1993,11,70-
  28. 75.
  29. [13] DeKretser, D. M., Burger, H. G., Hudson, B.: The relationship between germi-
  30. nal cells and serum FSH levels in male with infertility. J. Clin. Endocr. Metab. 1974,
  31. 35, 12-17.
  32. [14] Demkow, T., Faundez, R., Madej, G.: Ocena wybranych parametrów nasienia i
  33. poziomów hormonów FSH, LH, testosteronu u chorych na raka jądra. Doniesienie
  34. wstępne. Gin. Pol. 1998, 69, 405-409.
  35. [15] Demkow, T., Faundez, R.: Ocena zależności wybranych parametrów nasienia i
  36. poziomów hormonów FSH, LH i testosteronu od typu histologicznego nowotworu
  37. złośliwego. Nowotwory, 1999, 3, 285-288.
  38. [16] Drasga, R. E., Einhorn, L. H., Williams, S. D., Patel, D. N., Stevens, E.
  39. E.: Fertility after chemotherapy for testicular cancer. J. Clin. Oncol. 1983,1,179-
  40. 183.
  41. [17] DeSanties, M., Albrecht., W , Holtl, W., Pont, J.: Impact ofcytotoxic treat-
  42. ment on long-term fertility in patients with germ cell cancer. Int. J. Cancer 1999,
  43. 83, 864-865.
  44. [18] Forest, M. G., Lecoq, A., Saez, J. M.: Kinetics of human chorionic gonadotro-
  45. pin -induced steroidogenic response of human testis. J. Clin. Endocr. Metab. 1979,
  46. 49, 284-291.
  47. [19] Fossa, S. D., Aass, N.,- Molne, K.: Is routine pre-treatment cryopreseruation
  48. of semen worthwhile in the management of patients with testicular cancer? Br. J.
  49. Urol. 1989, 64, 524-529.
  50. [20] Fossa, S., Aabyholm, T., Vespestad, S., Norman, N., Ons, S.: Semen
  51. quality after treatment for testicular cancer. Eur. Urol. 1993, 23,172-176.
  52. [21] Fossa, S. D., Ons, S., Abyholm, T.: Post-treatment fertility in patients with
  53. testicular cancer. II. Influence of cisplatin-based Combination chemotherapy and ret-
  54. roperitoneal surgery on hormone and sperm cell production. Br. J. Urol. 1985, 57,
  55. 210-214.
  56. [22] Fossa, S. D., Ons, S., Abyholm, T.: Post-treatment fertility in patients with
  57. testicular cancer. Cancer 1985, 47, 210-214.
  58. [23] Fossa, S. D., Theodorsen, L., Norman, N.: Recovery of impaired pretreat-
  59. ment spermatogenesis in testicular cancer. Fertil. Steril. 1990, 54, 493-496.
  60. [24] Foster, R. S., Rubin, L. R., McNulty, A.: The detection of sperm antisperm
  61. antibodies in patients with primary testicular cancer. Int. Androl. 1991,14,179-
  62. 185.
  63. [25] Genesca, A., Miro, R., Caballin, M. R.: Sperm chromosome studies in indi-
  64. imiuals treated for testicular cancer. Hum. Reprod. 1990, 5, 286-290.
  65. [26] Giagulli, V. A., Vermeulen, A.: Leydig cell function in infertile men with idio-
  66. pathic oligospermic infertility. J. Clin. Endocr. Metab. 1988, 66, 62-76.
  67. [27] Guazzieri, S., Lembo, A., Ferro, G.: Sperm antibodies and infertility in patients
  68. with testicular cancer. Urology, 1985,26,139-143.
  69. [28] Hansen, S. W., Berthelsen, J. G., von der Maase, H.: Long-term fertility and
  70. Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine,
  71. and bleomycin versus surveillance. J. Clin. Oncol. 1990, 8,1695-1698.
  72. [29] Hansen, P. V., Glavind, K., Panduro, J., Pedersen, M.: Paternity in patients
  73. with testicular germ cell cancer: pretreatment and posttreatment findings. Eur. J.
  74. Cancer 1991, 27, 1385-1389.
  75. [30] Hansen, P. V., Trykker, H., Helkjaer, P. E., Andersen, J.: Testicular function
  76. in patients with testicular cancer treated with orchidectomy alone or orchidectomy
  77. plus cisplatin-based chemotherapy. J. Nat. Cancer Inst. 1989, 81,1246-1250.
  78. [31] Hendry, W. F., Stedronska, J., Jones, C. R.: Semen analysis in testicular cancer
  79. and Hodgkins disease: pre-and post treatment findings and implications for cryo-
  80. preservation. Br. J. Urol. 1983, 55, 769-773.
  81. [32] Herr, H. W., Bar-Chama, N., Osullivan, M., Sogani, P.: Paternity in men
  82. with stage I testis tumors on surveillance. J. Clin. Oncol. 1998,16, 733-734.
  83. [33] Kreuser, E. D., Harsch, U., Hetzel, W. D., Chreml, W.: Chronic gonadal
  84. toxicity in patients with testicular cancer after chemotherapy. Eur. J. Cancer 1986,
  85. 22, 289-294.
  86. [34] Krischner, M. A., Cohen, F. B., Jespersen, D.: Estrogen production and its
  87. origin in man with gonadotropin producing neoplasms. J. Clin. Endocr. Metab.
  88. 1974, 39, 112-118.
  89. [35] Lange, P. H., Chang, W. Y., Fraley, E. E.: Fertility issues in the therapy of
  90. nonseminomatous testicular tumors. Urol. Clin. N. Am. 1987,14, 731-746.
  91. [36] Le Blanc, G, A., Kantoff, W. P., Ng, S., Frei, E., Waxman, D. J.: Hormonal
  92. perturbation in patients with testicular cancer treated with cisplatin. Cancer, 1992,
  93. 69, 2306-2310.
  94. [37] Le Blanc, G. A., Waxman, D. J.: Feminzation of rat hepatic P-450 expression by
  95. cisplatin. J. Biol. Chem. 1988, 263, 15732-15739.
  96. [38] Lipshulz, L. J.: Cryptorchidism in the subfertile male. Peril. Steril. 1976,27,609-
  97. 613.
  98. [39] Maines, M. D., Sluss, P. M., Mumatz, I.: Cis-platinuin-mediated decrease in
  99. serum testosteron is associated with depression of luteinizing hormone receptors and
  100. cytochrome P-450 in rat testis. Endocrinologi, 1990,126, 2398-2406.
  101. [40] Martin, K, H., Ernst, S., Rademaker, A.: Analysis of human sperm karyotypes
  102. in testicular cancer patients before and after chemotherapy. Cytogen. Cell. Genet.
  103. 1997, 78, 120-123.
  104. [41] Martin, R. H.: Detection of genetic damage in human sperm. Repr. Toxicol. 1993,
  105. 7, 47-52.
  106. [42] Martin, R. M., Ernst, S., Rademaker, A., Barclay, L., Ko, E., Summers,
  107. N.: Chromosomal abnormalities in sperm from testicular cancer patients before and
  108. after chemotherapy. Hum. Genet,. 1997, 99.214-218.
  109. [43] Nijman, J. M., Schaffordt Koops, H., Kremer, J.: Gonadal function after sur-
  110. gery and chemotherapy in men with stage II and III nonseminomatous testicular
  111. tumors. J. Clin. Oncol. 1987, 5, 651-656.
  112. [44] Palmieri, G., Lotrecchiano, G., Ricci, G., Spiezia, R.: Gonadal function after
  113. multimodality treatment in men with testicular germ cell cancer. Eur. J. Endocr.
  114. 1996, 134, 431-436.
  115. [45] Presti, J., Harry, W., Herr, W., Carroll, P, R.: Fertility and testis cancer.
  116. Urol. Clin. N. Am. 1993, 20,173-179.
  117. [46] Sentirua, Y. D., Peckham, C. S., Peckham, M. J.: Children fathered by men
  118. treated for testicular cancer. Lancet, II, 766-769.
  119. [47] Stepans, A. V., Samaan, N. A., Schultz, P. N., Holoye, P, Y.: Endocrine
  120. studies in testicular tumor patients with and without gynecomastia. Cancer 1978,
  121. 41, 369-376.
  122. [48] Stephenson, T. W., Poirier, S. M., Rubin, L., Einhorn, L. H.: Evaluation
  123. of reproductive capacity in germ cell tumors patients following treatment with cis-
  124. platin, etoposide, and bleomycin. J. Clin. Oncol. 1995,13, 2278-2280.
  125. [49] Stuart, N. S. A., Woodroffe, R., Cullen, M. H.: Long-term toxicity of che-
  126. motherapy for testicular cancer - the cost of cure. Br. J. Cancer 1990, 61, 479-484.
  127. [50] Zorgniotti, A. W., MacLeod, J.: Studies in temperature, human semen quality
  128. and varicocele. Fertil. Steril. 1973, 24, 854-858.